The Need for Transitional Coverage for Emerging TechnologiesRegister
Contact InformationLuke Durocher
Join the Duke-Margolis Center for Health Policy, on Monday, March 28, 2022 at 12:00noon ET, as we partner with the Stanford Byers Center for Biodesign for a virtual event, The Need for Transitional Coverage for Emerging Technologies (TCET).
For patients on Medicare, the majority of whom are over age 65, time matters. However, newly published research from the Stanford Byers Center for Biodesign shows that patients can wait up to 5 years after FDA authorization to access new medical technologies.
Instead, a well-designed transitional coverage program could greatly accelerate patients’ access to care, while reducing the overall cost burden on our healthcare system. This program would also encourage innovation in areas of critically important unmet clinical needs.
The Duke-Margolis Center for Health Policy has recommended the addition of several key elements to a transitional coverage pathway, highlighting the need for early engagement between stakeholders to inform and guide evidence development and appropriate use of novel technologies.
Join us for this virtual event on March 28, to explore these findings and hear the perspectives of physicians, innovators, and CMS stakeholders on this important initiative to advance patient care.